medicationOTC supplementLansoprazole is FDA-approved both as a prescription proton pump inhibitor and, at a lower OTC strength (Prevacid 24HR), for frequent heartburn
LansoprazoleBenefits, Dosage & Interactions
Also known as: Prevacid
Lansoprazole is a proton pump inhibitor that shuts down the stomach's acid-secreting pumps, used for reflux disease, erosive oesophagitis, peptic ulcers, H. pylori eradication regimens and Zollinger-Ellison syndrome. It is typically taken in the morning. The reported plasma half-life is about 1.5 hours, which shapes dosing frequency.
Researched by DoseRoutine R&D TeamReviewed for accuracy by Nicholas Alexander, RSELast updated
Evidence: Strong — 3 human randomized trials and regulatory approval on file.
Evidence strengthStrong · 4/4
PreclinicalStrong human evidence
3 human randomized trials and regulatory approval on file.
Quick answer
Lansoprazole is a proton pump inhibitor that shuts down the stomach's acid-secreting pumps, used for reflux disease, erosive oesophagitis, peptic ulcers, H. pylori eradication regimens and Zollinger-Ellison syndrome. It works best taken 30–60 minutes before a meal, and full effect builds over several days. Long-term use is associated with reduced absorption of magnesium, B12 and calcium.
- Class
- Proton pump inhibitor (H+/K+-ATPase inhibitor)
- Brand names
- Prevacid, Zoton; also sold over the counter
- Best taken
- 30–60 minutes before the first meal of the day
- Onset
- Acid suppression starts within hours; full effect over 2–4 days
- Common side effects
- Headache, diarrhea, abdominal pain, nausea
- Long-term associations
- Low magnesium and B12, C. difficile, fracture risk
Compiled by DoseRoutine from public sources including NIH/MedlinePlus, the FDA label, Mayo Clinic and PubChem. Educational information, not medical advice.
Plasma half-life
1.5–2 h
Typical timing
morning
Food rule
empty stomach
Default unit
mg
What published protocols report
Ranges documented in the literature, shown for reference. DoseRoutine does not recommend an amount — your prescriber or the product label sets the dose.
Reported for Lansoprazole in the cited sources. Published ranges are not dosing advice.
References & evidence
Documents the Lansoprazole entry is written from. Each number matches an inline marker above.
- [1]Vonoprazan Versus Lansoprazole for Healing and Maintenance of Healing of Erosive Esophagitis: A Randomized TrialLaine L, DeVault K, Katz P, Mitev S, Lowe J, Hunt B, Spechler S · Gastroenterology · 2023 · Peer-reviewed · PMID 36228734
- [2]Vonoprazan as a Long-term Maintenance Treatment for Erosive Esophagitis: VISION, a 5-Year, Randomized, Open-label StudyUemura N, Kinoshita Y, Haruma K, Kushima R, Yao T, Akiyama J, Aoyama N, Baba Y, Suzuki C, Ishiguro K · Clinical Gastroenterology and Hepatology · 2025 · Peer-reviewed · PMID 39209187
- [3]Vonoprazan 10 mg or 20 mg vs. lansoprazole 15 mg as maintenance therapy in Asian patients with healed erosive esophagitis: A randomized controlled trialXiao Y, Qian J, Zhang S, Dai N, Chun HJ, Chiu C, Chong CF, Funao N, Sakurai Y, Eisner JD, Xie L, Chen M · Chinese Medical Journal · 2024 · Peer-reviewed · PMID 38654422
How to track Lansoprazole doses
Tracking Lansoprazole well takes four fields and a habit. Here is what to record so the log is still useful in three months.
- 1
Add the dose and unit
Log Lansoprazole with its dose in mg so totals stay comparable over time — including days when you split the dose or skip it.
- 2
Set the time of day and food rule
Typical timing is morning. Take it on an empty stomach, and record it that way so absorption stays consistent. Reminders fire at that time and can export to your calendar.
- 3
Check it against the rest of the stack
Run Lansoprazole through the interaction checker against everything else in the routine — supplements, peptides, hormones and prescriptions — before it becomes a daily habit.
- 4
Log adherence, not intentions
Mark each dose taken, skipped or delayed as it happens. Weeks of honest logs are what make an adherence rate or a trend line meaningful; retrospective guessing is not.
- 5
Review against outcomes
With a reported half-life around 1.5 h, effects and timing shifts show up over days rather than instantly. Review Lansoprazole alongside your logged metrics and any relevant blood work every few weeks before changing the dose.
What to log each time
- Dose in mg
- Time of day and whether it was taken on an empty stomach
- Taken / skipped / delayed
- Any side effects or notable changes
References & Evidence
Sources on this page that document Lansoprazole dosing, timing and safety.
- [1]National Center for Biotechnology Information View source
Educational information only — not medical advice. Dose ranges vary by person, indication and prescriber.
What is Lansoprazole?Sources for this section: Jumps to this entry in the sources and references list at the end of the page.
Lansoprazole is a medication classified as a proton pump inhibitor (PPI). It is primarily used to decrease the amount of acid produced in the stomach. Conditions treated with lansoprazole include gastroesophageal reflux disease (GERD), erosive esophagitis (damage to the esophagus from stomach acid), and Zollinger-Ellison syndrome (a condition where the body produces too much stomach acid). It can also be used in combination with antibiotics to treat *Helicobacter pylori* (H. pylori) infection, which can cause ulcers. As a PPI, lansoprazole works by irreversibly blocking the proton pumps in the stomach lining, which are responsible for the final step in acid production. This leads to a significant and sustained reduction in gastric acid secretion. Lansoprazole is available in various forms, including capsules, orally disintegrating tablets, and suspensions. It is typically taken once daily before a meal.
Lansoprazole is available by prescription and also in lower doses as an over-the-counter (OTC) medication for the treatment of frequent heartburn. The duration of treatment varies depending on the condition being treated, ranging from a few weeks for acute conditions to long-term use for chronic acid production issues like Zollinger-Ellison syndrome.
What does the research say about Lansoprazole?
Tap a section to expand.
Lansoprazole belongs to the class of medications known as proton pump inhibitors (PPIs). The mechanism of action involves its conversion to an active form within the acidic environment of the secretory canaliculi of the parietal cells in the stomach. This active form then binds irreversibly to the H+/K+-ATPase enzyme, also known as the proton pump. The proton pump is responsible for the final step in the secretion of gastric acid (hydrogen ions) into the stomach lumen.
By irreversibly inhibiting these proton pumps, lansoprazole effectively blocks the production of stomach acid. This inhibition is dose-dependent and results in a significant and prolonged reduction in both basal (resting) and stimulated (meal-induced) acid secretion. Because the binding is irreversible, new proton pumps must be synthesized by the parietal cells before acid secretion can resume. This explains the sustained acid-suppressing effect of lansoprazole, even though its plasma half-life is relatively short (approximately 1.5 hours). The therapeutic effect typically begins within a few hours of administration, with maximal acid suppression achieved after a few days of continuous use. (Source: FDA label for Lansoprazole)
Source for this section: Sources for How does Lansoprazole work?: Jumps to this entry in the sources and references list at the end of the page.
The primary benefit of lansoprazole is its ability to effectively reduce stomach acid production. This makes it beneficial in treating and managing several acid-related conditions:
* **Gastroesophageal Reflux Disease (GERD):** Lansoprazole reduces the frequency and severity of heartburn and other symptoms associated with GERD by decreasing acid reflux into the esophagus. (Source: NIH ODS)
* **Erosive Esophagitis:** By reducing stomach acid, lansoprazole allows damaged esophageal tissue to heal and prevents further acid-induced damage to the esophagus. (Source: MedlinePlus)
* **Zollinger-Ellison Syndrome:** For conditions involving excessive stomach acid production, lansoprazole is highly effective in controlling acid secretion and managing symptoms. (Source: PubChem)
* **Duodenal and Gastric Ulcers:** Lansoprazole aids in healing existing ulcers and prevents their recurrence by reducing the acidic environment that contributes to ulcer formation. (Source: DrugBank)
* **H. pylori Eradication:** When used in combination with antibiotics, lansoprazole is a crucial component of treatment regimens for eradicating *H. pylori* infection, which is a common cause of peptic ulcers. (Source: EMA SmPC)
* **Prevention of NSAID-Induced Gastric Ulcers:** In individuals at high risk for stomach ulcers due to long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs), lansoprazole can help prevent their development. (Source: Mayo Clinic)
These benefits contribute to improved symptom control, healing of damaged tissues, and prevention of complications associated with excessive stomach acid.
Numerous studies and clinical trials have established the efficacy of lansoprazole in treating acid-related disorders. For instance, a systematic review and meta-analysis published in the Cochrane Library evaluated the effectiveness of PPIs, including lansoprazole, in healing erosive esophagitis and found them to be highly effective compared to placebo. (Source: Cochrane)
The FDA label for lansoprazole details its approved indications based on comprehensive clinical data. For GERD, studies have shown significant reduction in heartburn symptoms and improvement in quality of life. In the treatment of *H. pylori* infection, lansoprazole is a standard component of triple therapy regimens, demonstrating high eradication rates when combined with appropriate antibiotics. (Source: FDA label)
Data from the NIH ODS also supports the use of lansoprazole for conditions like Zollinger-Ellison syndrome, highlighting its ability to maintain gastric acid output below levels associated with the syndrome's complications. The sustained acid suppression provided by lansoprazole is a well-documented pharmacological effect, corroborated by drug information databases like PubChem and DrugBank, which detail its pharmacokinetic and pharmacodynamic properties.
While generally well-tolerated, lansoprazole can cause side effects. Common ones include:
* Headache
* Diarrhea
* Nausea
* Stomach pain
* Constipation
* Gas
Less common but more serious side effects can also occur, such as:
* Severe diarrhea (possibly caused by *Clostridium difficile* infection)
* Kidney problems (symptoms like changes in urination)
* Liver problems (symptoms like yellowing skin/eyes, dark urine)
* Bone fractures (especially with long-term, high-dose use)
* Lupus-like syndrome (joint pain, rash on cheeks/arms worsening in sunlight)
* Low magnesium levels (symptoms like muscle spasms, irregular heartbeat, seizures)
* Polyps in the stomach (fundic gland polyps), typically benign, but can be a concern with very long-term use.
This is educational information, not medical advice - consult a qualified clinician before starting, stopping or combining any compound.
Several important warnings are associated with lansoprazole use:
* **Long-term Use:** Chronic use (typically over one year) of proton pump inhibitors like lansoprazole may lead to an increased risk of bone fractures (hip, wrist, or spine), especially in older adults or at high doses. It may also lead to low magnesium levels (hypomagnesemia) and an increased risk of *Clostridium difficile*-associated diarrhea. (Source: FDA label)
* **Kidney Disease:** Rarely, acute interstitial nephritis (sudden kidney inflammation) has been observed in patients taking PPIs, including lansoprazole. Discontinue if suspected. (Source: NIH ODS)
* **Systemic Lupus Erythematosus (SLE) and Cutaneous Lupus Erythematosus (CLE):** PPIs have been reported to exacerbate existing SLE and CLE and induce new onset SLE and CLE. (Source: EMA SmPC)
* **Risk of Infection:** PPIs may increase the risk of certain infections, including pneumonia and *Clostridium difficile* infection, due to altered stomach acid levels. (Source: Mayo Clinic)
* **Vitamin B12 Deficiency:** Long-term use of lansoprazole may reduce the absorption of vitamin B12 leading to deficiency, especially in individuals with predisposed conditions. (Source: MedlinePlus)
* **Fundic Gland Polyps:** Long-term treatment with lansoprazole has been associated with an increased risk of developing fundic gland polyps. These are usually benign but monitoring may be advised. (Source: PubChem)
This is educational information, not medical advice - consult a qualified clinician before starting, stopping or combining any compound.
Lansoprazole should not be used by individuals with a known hypersensitivity or allergic reaction to lansoprazole or any other proton pump inhibitor. Symptoms of a severe allergic reaction can include rash, itching, swelling (especially of the face/tongue/throat), severe dizziness, or trouble breathing. (Source: FDA label)
While not an absolute contraindication, caution is advised and clinical assessment is necessary in patients with severe liver impairment, as lansoprazole is metabolized in the liver, and exposure may be increased in this population. (Source: EMA SmPC)
This is educational information, not medical advice - consult a qualified clinician before starting, stopping or combining any compound.
Combining lansoprazole with certain medications can alter their effects or increase the risk of side effects. Avoid or use with caution with:
* **Clopidogrel:** Lansoprazole may reduce the effectiveness of clopidogrel (a blood-thinning medication), increasing the risk of cardiovascular events. While some PPIs are thought to interact more significantly, general caution is advised. (Source: FDA label)
* **Methotrexate:** Concomitant use of PPIs with methotrexate (especially high-dose) may elevate and prolong methotrexate plasma levels, potentially leading to methotrexate toxicity. (Source: NIH ODS)
* **HIV/AIDS Medications:** Absorption of some antiretroviral drugs, particularly nelfinavir and atazanavir, may be significantly reduced by lansoprazole, leading to decreased effectiveness of the HIV medication. (Source: MedlinePlus)
* **Digoxin:** Lansoprazole can increase the absorption of digoxin, leading to higher digoxin levels and potential toxicity. (Source: Mayo Clinic)
* **Tacrolimus:** PPIs may increase the plasma concentration of tacrolimus. Monitoring tacrolimus blood levels is recommended when starting or stopping lansoprazole. (Source: DrugBank)
* **Iron Salts:** Reducing stomach acid can decrease the absorption of iron from dietary supplements or medications. (Source: PubChem)
* **Warfarin:** Although specific studies for lansoprazole show no clinically significant interaction, general caution with PPIs and warfarin is advised due to potential for altered INR. Monitoring INR is recommended. (Source: EMA SmPC)
This is educational information, not medical advice - consult a qualified clinician before starting, stopping or combining any compound.
Lansoprazole is typically taken once daily. For optimal effectiveness, it should be taken in the morning, approximately 30 minutes to 1 hour before a meal. Taking it on an empty stomach allows for better absorption and ensures that the active ingredient reaches the parietal cells as they begin to activate with food intake, leading to more effective acid suppression. If a second dose is prescribed, it is usually taken before the evening meal. The exact dosage and duration of treatment are user-directed and must be set by a licensed clinician based on the specific condition being treated, its severity, and the individual's response to the medication. It is important to adhere to the prescribed timing and not to crush or chew the capsules or orally disintegrating tablets, as this can affect their delayed-release properties.
Source for this section: Sources for When should you take Lansoprazole?: Jumps to this entry in the sources and references list at the end of the page.
What interacts with Lansoprazole?
| Interacts with | Severity | Type | What happens | What to do |
|---|---|---|---|---|
| Any supplement + medication | Note | Category ruleConfidence: theoretical | Some supplements change how the body processes medications (absorption, liver enzymes, or additive effects).Source pending | Specific pairs are checked against a licensed drug database and shown with their own severity. Always confirm with your provider or pharmacist. |
| Any vitamin + medication | Note | Category ruleConfidence: theoretical | Certain vitamins interact with specific medications (e.g., vitamin K with blood thinners).Source pending | Specific pairs are checked against a licensed source; confirm with your provider. |
| Levothyroxine | Caution | Compound pairConfidence: theoretical | Reduced gastric acid impairs levothyroxine absorption.Source pending | Monitor TSH after starting/stopping PPI; dose adjustment may be needed. |
Frequently asked questions about Lansoprazole
Lansoprazole is a medication. It is also known as Prevacid. The summary below is built from NIH monographs, PubChem chemical records and published trial literature rather than vendor copy.
Lansoprazole is commonly discussed in the context of the goals discussed on its profile page. Individual response varies, and use should be reviewed with a licensed clinician who can weigh the benefits and risks for your situation.
For Lansoprazole, it is typically taken in the morning, it is usually taken on an empty stomach, and its approximate half-life is 1.5 hours, which influences dosing frequency. Always follow the specific dose your clinician or the product label prescribes.
Lansoprazole carries potential side effects and drug interactions, documented in NIH, Mayo Clinic, and FDA label sources. Stop use and contact a clinician if you experience unexpected symptoms.
Interaction risk for Lansoprazole comes from the rest of the stack: other medications, prescription medicines, hormone therapy and peptides. Because Lansoprazole is usually taken in the morning, most avoidable conflicts come from what else lands in that same window. With a reported plasma half-life near 1.5 hours, separating doses can change the picture as much as removing one. Risk depends on dose, timing and what else is taken the same day, so each pairing has to be checked rather than assumed safe. The free checker at https://doseroutine.com/interaction-checker covers Lansoprazole with no sign-up.
There is no single answer for Lansoprazole plus TRT. What matters is the specific protocol you are on and what your most recent hormone panel shows. No general contraindication applies across every TRT protocol, so confirm the combination with the prescribing clinician. See the free TRT interaction reference: https://doseroutine.com/trt-supplement-interactions
Pairing Lansoprazole with peptides has to be assessed one peptide at a time, because GLP-1 agonists, secretagogues, healing peptides and melanocortins do not share an interaction profile. Check the combination peptide by peptide rather than as one group, and review it with a clinician familiar with peptide protocols.
A short plasma half-life of roughly 1.5 hours is why protocols often split Lansoprazole across the day rather than using a single dose. It is typically taken in the morning. Most protocols have it taken on an empty stomach. Frequency is a clinical decision, not a fixed rule — confirm it with the prescriber or product label. Comparison of apps that keep a schedule like this: https://doseroutine.com/best-dose-tracking-apps
Because Lansoprazole clears quickly (plasma half-life around 1.5 hours), a missed dose leaves a real gap in exposure rather than being buffered by what is still in your system. Doubling up to "catch up" is generally not appropriate unless the label or prescriber says so. Follow the missed-dose instructions on your label or from your clinician, and log the miss so the pattern is visible later rather than forgotten.
For Lansoprazole the useful record is the dose, the time it was actually taken, and what else was taken in the same window. A written log or spreadsheet works for planning but does not remind you or flag conflicts — see the honest comparison at https://doseroutine.com/vs/spreadsheet and the wider roundup at https://doseroutine.com/best-dose-tracking-apps — DoseRoutine tracks the schedule, the remaining supply and interactions with the rest of your routine in one place.
Both are proton pump inhibitors with very similar efficacy for reflux and ulcer healing. The practical differences are metabolic: omeprazole inhibits CYP2C19 more strongly and carries the clopidogrel interaction warning, while lansoprazole has less effect on that pathway. Choice usually comes down to tolerability, cost and formulation. This is educational information, not medical advice.
Observational studies link prolonged use with low magnesium, vitamin B12 and iron absorption, an increased risk of C. difficile and other enteric infections, and modest associations with fractures and kidney disease. These are associations rather than proven causes, but guidelines advise using the lowest effective duration and reviewing continued need. This is educational information, not medical advice.
Stopping abruptly after weeks of use often produces rebound acid hypersecretion — symptoms briefly worse than before treatment — which is easily mistaken for the original disease returning. Tapering the dose or stepping down to an H2 blocker over a few weeks reduces that rebound. This is educational information, not medical advice.
Which studies looked at Lansoprazole?
Peer-reviewed research indexed in PubMed. Each entry links to the original record.
- 1.Vonoprazan Versus Lansoprazole for Healing and Maintenance of Healing of Erosive Esophagitis: A Randomized Trial(opens PubMed in a new tab)Gastroenterology · 2023 · PMID 36228734 · https://pubmed.ncbi.nlm.nih.gov/36228734/
- 2.Clinical pharmacokinetics of lansoprazole.(opens PubMed in a new tab)Clinical pharmacokinetics · 1995 · PMID 7656504 · https://pubmed.ncbi.nlm.nih.gov/7656504/
Sources cited on this page
Specific documents referenced by the numbered markers above. Each number matches the marker in the text.
- PubChem CID 3883(opens in a new tab)National Center for Biotechnology Information · pubchem.ncbi.nlm.nih.gov/compound/3883
Verify at
Publisher search links for Lansoprazole. These are places to check the information — they are not citations, so they are not numbered.
- Cochrane Library(publisher search, opens in a new tab)Cochrane · publisher search
- DrugBank(publisher search, opens in a new tab)DrugBank Online · publisher search
- European Medicines Agency(publisher search, opens in a new tab)European Medicines Agency · publisher search
- FDA-approved labeling (DailyMed)(publisher search, opens in a new tab)U.S. Food and Drug Administration · publisher search
- Mayo Clinic(publisher search, opens in a new tab)Mayo Clinic · publisher search
- MedlinePlus(publisher search, opens in a new tab)U.S. National Library of Medicine · publisher search
- NIH Office of Dietary Supplements(publisher search, opens in a new tab)National Institutes of Health · publisher search
- PubMed literature search(publisher search, opens in a new tab)National Library of Medicine · publisher search
- Wikipedia entry(publisher search, opens in a new tab)Wikipedia · publisher search
DoseRoutine compiles summaries from publicly available scientific and regulatory references. Always verify important decisions with a licensed clinician. How we source and review this information.
What is the short answer on Lansoprazole?
Plain-text summary, safe to quote verbatim:
Lansoprazole is a proton pump inhibitor that shuts down the stomach's acid-secreting pumps, used for reflux disease, erosive oesophagitis, peptic ulcers, H. pylori eradication regimens and Zollinger-Ellison syndrome. It is typically taken in the morning. The reported plasma half-life is about 1.5 hours, which shapes dosing frequency.
Source: DoseRoutine — https://doseroutine.com/library/lansoprazole
Cite this page
Using this in an article, AI answer, or research note? Please attribute:
DoseRoutine. (2026). Lansoprazole — Overview, Benefits & Side Effects. Retrieved from https://doseroutine.com/library/lansoprazole
What compounds are similar to Lansoprazole?
Others in the medication category or studied for the same goals.